Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

Dysregulated Protease Homeostasis Defines Primary FSGS

View through CrossRef
Key Points Serum proteomics reveals reduced serpin family A member 1 ( SERPINA1 ) in primary FSGS, distinguishing it from other proteinuric kidney diseases. Serpina1 knockdown in zebrafish causes proteinuria and edema, supporting its functional relevance in glomerular disease. SERPINA1 may exert compartment-specific functions, and its decrease may permit protease activity to contribute to podocyte injury in primary FSGS. Background Primary FSGS (pFSGS) is caused by circulating permeability factors. Despite extensive efforts, no single causative factor or biomarker signature has been identified that reliably predicts disease or therapeutic outcomes across all patients. By using liquid chromatography-mass spectrometry–based proteomics on serum samples from patients with pFSGS, compared with controls, we aimed to identify disease-specific protein signatures. Methods Liquid chromatography-mass spectrometry–based proteomics analysis was performed on 103 serum samples from 36 patients with pFSGS, 33 patients with other proteinuric diseases, and 34 healthy controls. Selected proteins found to be dysregulated in pFSGS were tested in cell culture experiments in immortalized human podocytes. Knockdown experiments were performed in zebrafish larvae, which were screened for proteinuria, edema, and podocyte marker expression. Immunofluorescent staining on zebrafish sections and patients' kidney biopsies was used to confirm findings. Results Mass spectrometry of sera from patients revealed a set of 27 proteins specifically affected in pFSGS, including a dysbalance of proteases and protease inhibitors. A subset of younger pFSGS patients with frequent relapses showed a distinct serum protein profile based on 23 dysregulated proteins. From proteomics results, serpin family A member 1 ( SERPINA1 ; α -1-antitrypsin) was selected for further investigations. Urinary SERPINA1 increased across nephrotic syndromes, whereas serum SERPINA1 reduction was specific to pFSGS, suggesting a distinct underlying pathophysiology involving immune modulation, increased protease activity, or systemic depletion. Glomerular SERPINA1 expression was selectively increased in sclerotic lesions, likely reflecting a local compensatory response to protease stress. Podocytes constitutively secreted SERPINA1 , with limited adaptive response under protease stress. Finally, systemic Serpina1 knockdown in zebrafish induced edema, proteinuria, and loss of slit diaphragm markers. Conclusions Our findings support a causal and compartment-specific role of SERPINA1 and suggest that reduced circulating protease inhibitors may shift the local protease-antiprotease balance, potentially facilitating podocyte injury in pFSGS.
Title: Dysregulated Protease Homeostasis Defines Primary FSGS
Description:
Key Points Serum proteomics reveals reduced serpin family A member 1 ( SERPINA1 ) in primary FSGS, distinguishing it from other proteinuric kidney diseases.
Serpina1 knockdown in zebrafish causes proteinuria and edema, supporting its functional relevance in glomerular disease.
SERPINA1 may exert compartment-specific functions, and its decrease may permit protease activity to contribute to podocyte injury in primary FSGS.
Background Primary FSGS (pFSGS) is caused by circulating permeability factors.
Despite extensive efforts, no single causative factor or biomarker signature has been identified that reliably predicts disease or therapeutic outcomes across all patients.
By using liquid chromatography-mass spectrometry–based proteomics on serum samples from patients with pFSGS, compared with controls, we aimed to identify disease-specific protein signatures.
Methods Liquid chromatography-mass spectrometry–based proteomics analysis was performed on 103 serum samples from 36 patients with pFSGS, 33 patients with other proteinuric diseases, and 34 healthy controls.
Selected proteins found to be dysregulated in pFSGS were tested in cell culture experiments in immortalized human podocytes.
Knockdown experiments were performed in zebrafish larvae, which were screened for proteinuria, edema, and podocyte marker expression.
Immunofluorescent staining on zebrafish sections and patients' kidney biopsies was used to confirm findings.
Results Mass spectrometry of sera from patients revealed a set of 27 proteins specifically affected in pFSGS, including a dysbalance of proteases and protease inhibitors.
A subset of younger pFSGS patients with frequent relapses showed a distinct serum protein profile based on 23 dysregulated proteins.
From proteomics results, serpin family A member 1 ( SERPINA1 ; α -1-antitrypsin) was selected for further investigations.
Urinary SERPINA1 increased across nephrotic syndromes, whereas serum SERPINA1 reduction was specific to pFSGS, suggesting a distinct underlying pathophysiology involving immune modulation, increased protease activity, or systemic depletion.
Glomerular SERPINA1 expression was selectively increased in sclerotic lesions, likely reflecting a local compensatory response to protease stress.
Podocytes constitutively secreted SERPINA1 , with limited adaptive response under protease stress.
Finally, systemic Serpina1 knockdown in zebrafish induced edema, proteinuria, and loss of slit diaphragm markers.
Conclusions Our findings support a causal and compartment-specific role of SERPINA1 and suggest that reduced circulating protease inhibitors may shift the local protease-antiprotease balance, potentially facilitating podocyte injury in pFSGS.

Related Results

Clinicopathological Outcomes in Focal Segmental Glomerulosclerosis: A Retrospective Cohort Study
Clinicopathological Outcomes in Focal Segmental Glomerulosclerosis: A Retrospective Cohort Study
Introduction: Focal Segmental Glomerulosclerosis (FSGS) is a nephrotic syndrome with a variety of clinicopathological presentations and varied responses to treatment. Hence, this s...
Novel diagnostic and therapeutic techniques reveal changed metabolic profiles in recurrent focal segmental glomerulosclerosis
Novel diagnostic and therapeutic techniques reveal changed metabolic profiles in recurrent focal segmental glomerulosclerosis
Abstract Idiopathic forms of Focal Segmental Glomerulosclerosis (FSGS) are caused by circulating permeability factors, which can lead to early recurrence of FSGS ...
Novel Diagnostic and Therapeutic Techniques Reveal Changed Metabolic Profiles in Recurrent Focal Segmental Glomerulosclerosis 
Novel Diagnostic and Therapeutic Techniques Reveal Changed Metabolic Profiles in Recurrent Focal Segmental Glomerulosclerosis 
Abstract Idiopathic forms of Focal Segmental Glomerulosclerosis (FSGS) are caused by circulating permeability factors, which can lead early recurrence of FSGS and kidney fa...
Value of urinary CD80 in differentiating minimal change disease from focal segmental glomerulosclerosis
Value of urinary CD80 in differentiating minimal change disease from focal segmental glomerulosclerosis
Background. Minimal change disease (MCD) and focal segmental glomerulosclerosis (FSGS) are two common forms of childhood nephrotic syndrome (NS). Separating MCD from FSGS is essent...
Nephroprotective Effects of Curcumin in Murine Models of Focal and Segmental Glomerulosclerosis
Nephroprotective Effects of Curcumin in Murine Models of Focal and Segmental Glomerulosclerosis
Introduction: This study aims to explore the reno-protective effect of curcumin in focal and segmental glomerulosclerosis (FSGS) in murine models, a common chronic glomerulopathy t...

Back to Top